SIAP
PRME icon

Sterling Investment Advisors (Pennsylvania)’s Prime Medicine PRME Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.6K Hold
13,400
– – 0.01% 211
2025
Q4 		$46.5K Buy
13,400
+3,400
+34% +$15.1K 0.01% 208
2025
Q3 		$55.4K Buy
+10,000
New +$40.6K 0.01% 197

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s PRME Position: Q1 2026 in Review

Sterling Investment Advisors (Pennsylvania) held its Prime Medicine (PRME) position steady in Q1 2026 at 13,400 shares worth $46.6K. The position accounts for 0.01% of the portfolio, ranked #211.

Sterling Investment Advisors (Pennsylvania) first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. The position peaked at $55.4K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Sterling Investment Advisors (Pennsylvania) held 13,400 shares of Prime Medicine worth $46.6K as of Q1 2026.
  • Sterling Investment Advisors (Pennsylvania) left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up 0.01% of Sterling Investment Advisors (Pennsylvania)'s portfolio in Q1 2026, its #211 holding.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • Sterling Investment Advisors (Pennsylvania)'s Prime Medicine position peaked at $55.4K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q1 2026, filed 4 May 2026.